- Eupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory Board
- Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024
- Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference
- Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today
- Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024
- Eupraxia Pharmaceuticals Reports Fourth Quarter and 2023 Financial Results
- Canadian Investment Regulatory Organization Trade Resumption - EPRX
- Canadian Investment Regulatory Organization Trading Halt - EPRX
- Eupraxia Pharmaceuticals Announces Updated Positive Clinical Data in EP-104GI RESOLVE Trial for the Treatment of Eosinophilic Esophagitis
More ▼
Key statistics
On Friday, Eupraxia Pharmaceuticals Inc (EPRX:TOR) closed at 3.94, 14.53% above the 52 week low of 3.44 set on Apr 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.76 |
---|---|
High | 3.98 |
Low | 3.76 |
Bid | 3.90 |
Offer | 3.95 |
Previous close | 3.72 |
Average volume | 23.60k |
---|---|
Shares outstanding | 35.62m |
Free float | 33.24m |
P/E (TTM) | -- |
Market cap | 140.35m CAD |
EPS (TTM) | -1.60 CAD |
Data delayed at least 15 minutes, as of May 03 2024 20:59 BST.
More ▼